About ByBug
At ByBug, we are redefining how the world produces therapeutic proteins. Our breakthrough lies in a new paradigm of biomanufacturing: a platform powered by genetically enhanced Hermetia illucens larvae engineered to produce recombinant proteins and veterinary therapeutics with unprecedented efficiency. By transforming insect larvae into next-generation biofactories, we enable a production model that is 100× more cost-effective and up to 150× more sustainable than conventional systems—unlocking a future where life-saving and life-enhancing biomolecules can be manufactured at scale, with minimal environmental impact. We are not just improving biomanufacturing. We are reinventing it.
Founded in 2021 by Daniel Sebastián Troncoso Espinosa, Gerardo Bluske Moscoso, José Ignacio Del Solar Bou and Rocío del Carmen Espinosa Torres.
- Founded
- 2021
- Employees
- 11 to 50
- Total funding
- $1.4M
- Headquarters
- Chile
Leadership
The top of ByBug's org chart, with how many people report into each leader.
Gerardo Bluske
Co-Founder & CBO
Jobs at ByBug
No open positions right now. Explore more companies on TheJobsMap.